Name: UMIN ID:
Unique ID issued by UMIN | UMIN000027209 |
---|---|
Receipt number | R000031174 |
Scientific Title | Phase I/II clinical trial of verification for the safety and efficacy of Amitose-Bis-glyceryl ascorbate-containing cream in renal cell carcinoma patients treated by sunitinib |
Date of disclosure of the study information | 2018/12/27 |
Last modified on | 2022/05/06 09:03:34 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/05/01 12:48:27 | ||
2 | Update | 2018/12/27 14:57:15 | Recruitment status Date of protocol fixation Anticipated trial start date |
|
3 | Update | 2018/12/27 15:02:03 | Last name of lead principal investigator Last name of lead principal investigator Division name Division name Date of disclosure of the study information |
|
4 | Update | 2020/11/02 12:24:33 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
5 | Update | 2020/11/02 12:32:38 | Date of IRB Last follow-up date |
|
6 | Update | 2021/05/19 11:05:27 | Recruitment status Last follow-up date |
|
7 | Update | 2022/05/06 08:59:19 | Recruitment status |
|
8 | Update | 2022/05/06 09:03:34 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled |